{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:45:17Z","timestamp":1789757117838,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd011313","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T00:00:00Z","timestamp":1455580800000}}],"reference-count":74,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011313.pub2","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T01:26:06Z","timestamp":1456363566000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma"],"prefix":"10.1002","author":[{"given":"Omar M","family":"Abdel-Rahman","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Ain Shams University; Clinical Oncology; Lofty Elsayed Street Cairo Egypt 11335"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Elsayed","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ain Shams University; Clinical Oncology; Lofty Elsayed Street Cairo Egypt 11335"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,2,16]]},"reference":[{"key":"10.1002\/14651858.CD011313.pub2-BIB0001|cit1","doi-asserted-by":"crossref","unstructured":"Kolligs F Bilbao J Jakobs T I\u00f1arrairaegui M Nagel J Rodriguez M Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma Liver International 2015 1715 21","DOI":"10.1111\/liv.12750"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/liv.12622","article-title":"Safety and toxicity of radioembolization plus sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC","volume":"35","author":"Ricke","year":"2015","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/liv.12637","article-title":"In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?","volume":"35","author":"Fouly","year":"2015","journal-title":"Liver International"},{"issue":"2","key":"10.1002\/14651858.CD011313.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jhep.2014.03.023","article-title":"Prospective randomized pilot study of Y90 +\/- sorafenib as bridge to transplantation in hepatocellular carcinoma","volume":"61","author":"Kulik","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD011313.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study","volume":"57","author":"Mazzaferro","year":"2013","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0006|cit6","unstructured":"An Investigator Initiated Multicenter Prospective Randomised Study of Chemoembolisation Versus Radioembolisation for the Treatment of Hepatocellular Carcinoma (PREMIERE Trial) Ongoing study August 2009."},{"key":"10.1002\/14651858.CD011313.pub2-BIB0007|cit7","unstructured":"Transarterial Radioembolisation Versus Chemoembolisation for the Treatment of HCC: a Multicenter Randomised Controlled Trial (TRACE trial). Ongoing study September 2011."},{"key":"10.1002\/14651858.CD011313.pub2-BIB0008|cit8","unstructured":"A Prospective Randomised Open-Labelled Trial Comparing Radioembolisation with Yttrium 90 Microspheres and Sorafenib in Patients with Advanced Hepatocellular Carcinoma. Ongoing study December 2011."},{"key":"10.1002\/14651858.CD011313.pub2-BIB0009|cit9","unstructured":"A Phase III Clinical Trial of Intra-Arterial TheraSphere\u00ae in the Treatment of Patients with Unresectable Hepatocellular Carcinoma. Ongoing study"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0010|cit10","unstructured":"A Randomized, Multi-center, Open Label, Phase 3 Trial Comparing Conventional TACE and Transarterial Radioembolisation in Patients with Unilobar Advanced Hepatocellular Carcinoma. Ongoing study April 2013."},{"key":"10.1002\/14651858.CD011313.pub2-BIB0011|cit11","doi-asserted-by":"crossref","unstructured":"Abdel-Rahman O Abdelwahab M Shaker M Abdelwahab S Elbassiouny M Ellithy M Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience Journal of the Egyptian National Cancer Institute 2014 9 13 10.1016\/j.jnci.2013.08.003","DOI":"10.1016\/j.jnci.2013.08.003"},{"issue":"12","key":"10.1002\/14651858.CD011313.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1007\/s10620-0132872-x","article-title":"Combination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature","volume":"58","author":"Abdel-Rahman","year":"2013","journal-title":"Digestive Disease and Science"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines 3: rating the quality of evidence - introduction","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"28","key":"10.1002\/14651858.CD011313.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.3748\/wjg.14.4445","article-title":"Hepatocellular carcinoma: defining the place of surgery in an era of organ shortage","volume":"14","author":"Bartlett","year":"2008","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive - trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD011313.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0018|cit18","unstructured":"Cochrane Hepato-Biliary Group Module hbg.cochrane.org"},{"issue":"96","key":"10.1002\/14651858.CD011313.pub2-BIB0019|cit19","first-page":"1683","article-title":"A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma","volume":"56","author":"D'Avola","year":"2009","journal-title":"Hepato-gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011313.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods of combining randomised clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011313.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD011313.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association for the Study of the Liver","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.1002\/14651858.CD011313.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0025|cit25","unstructured":"Functional Assessment of Cancer Therapy-Hepatobiliary tumors (FACT-Hep) www.facit.org\/FACITOrg\/Questionnaires"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0026|cit26","unstructured":"Brozek J Oxman A Sch\u00fcnemann H GRADEpro 2008"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.transproceed.2012.07.151","article-title":"Transplantation for hepatocellular carcinoma in younger patients has an equivocal survival advantage as compared with resection","volume":"45","author":"Graham","year":"2013","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines 4: rating the quality of evidence - risk of bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines 5: rating the quality of evidence - publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0033|cit33","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0035|cit35","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"11","key":"10.1002\/14651858.CD011313.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomised trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jso.20609","article-title":"Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: down staging to resection, RFA and bridge to transplantation","volume":"94","author":"Kulik","year":"2006","journal-title":"Journal of Surgical Oncology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.alcohol.2012.03.006","article-title":"Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: a case-control study","volume":"46","author":"Kwon","year":"2012","journal-title":"Alcohol (Fayetteville, N.Y.)"},{"issue":"6","key":"10.1002\/14651858.CD011313.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/gut.50.6.881","article-title":"Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto","volume":"50","author":"Levy","year":"2002","journal-title":"Gut"},{"issue":"8","key":"10.1002\/14651858.CD011313.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A comparative analysis of transarterial down staging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"American Journal of Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD011313.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"e103228","DOI":"10.1371\/journal.pone.0103228","article-title":"Prognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou Criteria Staging Systems","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1002\/14651858.CD011313.pub2-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub2","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011313.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MNM.0b013e3283619d24","article-title":"The PERCIST criteria: an insightful appraisal","volume":"34","author":"Maffione","year":"2013","journal-title":"Nuclear Medicine Communications"},{"issue":"4","key":"10.1002\/14651858.CD011313.pub2-BIB0045|cit45","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"2","author":"Mantel","year":"1959","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-60327-376-3_8","article-title":"Hepatitis C and hepatocellular carcinoma","volume-title":"Hepatocellular Carcinoma Diagnosis and Treatment","author":"Masuzaki","year":"2009"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"9128","key":"10.1002\/14651858.CD011313.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/978-1-60327-522-4_20","article-title":"Yttrium-90 radioembolotherapy for hepatocellular cancer","volume-title":"Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary Care","author":"Murthy","year":"2011"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients","volume":"56","author":"Okuda","year":"1985","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD011313.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004787.pub2","article-title":"Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma","author":"Oliveri","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"24","key":"10.1002\/14651858.CD011313.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0053|cit53","unstructured":"The Nordic Cochrane Centre, Cochrane Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/01.RVI.0000177063.92678.21","article-title":"The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma","volume":"16","author":"Rhee","year":"2005","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"4","key":"10.1002\/14651858.CD011313.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jhep.2010.10.004","article-title":"Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation","volume":"54","author":"Riaz","year":"2011","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011313.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomised controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD011313.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","article-title":"The etiology of hepatocellular carcinoma and consequences for treatment","volume":"15","author":"Sanyal","year":"2010","journal-title":"Oncologist"},{"issue":"35","key":"10.1002\/14651858.CD011313.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD011313.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011313.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4149\/av_2012_03_235","article-title":"Hepatitis C virus and other risk factors in hepatocellular carcinoma","volume":"56","author":"Schiefelbein","year":"2012","journal-title":"Acta Virologica"},{"issue":"5","key":"10.1002\/14651858.CD011313.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD011313.pub2-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006935.pub2","article-title":"Surgical resection versus liver transplant for patients with hepatocellular carcinoma","author":"Taefi","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0065|cit65","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0066|cit66","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual forTrial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0067|cit67","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis 2011"},{"issue":"4","key":"10.1002\/14651858.CD011313.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00330-008-1211-7","article-title":"Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis","volume":"19","author":"Vente","year":"2009","journal-title":"European Radiology"},{"issue":"12","key":"10.1002\/14651858.CD011313.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003046.pub3","article-title":"Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma","author":"Weis","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub2-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006745.pub3","article-title":"Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma","author":"Weis","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in a random-effects meta-analysis","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD011313.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"42","key":"10.1002\/14651858.CD011313.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.3748\/wjg.14.6437","article-title":"Evolution of systemic therapy of advanced hepatocellular carcinoma","volume":"14","author":"Yau","year":"2008","journal-title":"World Journal of Gastroenterology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011313.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011313.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:54:48Z","timestamp":1628549688000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011313.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,16]]},"references-count":74,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011313.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD011313.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,16]]}}}